News search
Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
About the CNIC 29 Nov 2023 CNIC and the i+12 Institute co-lead one of the working groups of this initiative. |
Research 20 Nov 2023 Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough |
Research 2 Oct 2023 Scientists at the CNIC have discovered that metabolic cardiovascular risk factors diminish the capacity of the heart to use glucose as an energy source |
About the CNIC 29 Sep 2023 The Spanish National Centre for Cardiovascular Research (CNIC) researcher Dr Ana Paredes has won the International Birnstiel Award 2023 |
Research 31 Aug 2023 A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over 5 years |
Research 29 May 2023 The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer |
- ‹ previous
- 2 of 14
- next ›